Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02609919 · ClinicalTrials.gov registry record
Assessment of Immediate Adverse Reactions From Dotarem in Children Under 2 Years of Age
A clinical trial of Adverse Reaction to Drug and Allergic Reaction to Contrast Media, sponsored by St. Louis University.
- Completed
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT02609919: Completed study of Adverse Reaction to Drug and Allergic Reaction to Contrast Media, sponsored by St. Louis University.
NCT02609919 is a study of Adverse Reaction to Drug and Allergic Reaction to Contrast Media that has completed, run by St. Louis University. The registered enrollment target is 150 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02609919, a study of Adverse Reaction to Drug and Allergic Reaction to Contrast Media, has completed, sponsored by St. Louis University.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
Our primary outcome is to assess the safety of Dotarem in children \<2 years old up to 24 hours after Dotarem injection. Patients will be monitored for any adverse events that occur for 2 hours following the completion of the MRI exam. The type of event, time of onset, duration of symptoms, intensity of the reaction (mild, moderate, severe), causality (not related, probably related, related, definitely related, unclassifiable), and subsequent outcome (required treatment, favorable outcome, recovery with sequela, or death) will be documented. Parents will be given instruction sheets on who and when to call should any adverse event occur after discharge. Parents will be called by the radiology department the next day to identify any adverse events that occurred during the first 24 hours after discharge from the hospital. Our secondary outcome is to assess image quality of the exam. The pre-contrast images will be compared to the combined pre- and post-contrast images following administration of Dotarem by radiologists who are blinded to the patients' clinical information to assess for improvement of image quality and delineation of structures with contrast.
Primary Outcome
Safety and efficacy
Conditions Studied
Interventions
- DRUG Gadoteric Acid
Study Locations (1)
Missouri
- Saint Louis University - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2016-01 |
| Est. Completion | 2019-07-19 |
What the finished NCT02609919 record still lists
NCT02609919 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.
The record links to 2 conditions, with Adverse Reaction to Drug appearing as the primary indexed condition, and to 1 intervention - of which Gadoteric Acid is the first listed.
NCT02609919 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT02609919 about?
NCT02609919 is a clinical study titled "Assessment of Immediate Adverse Reactions From Dotarem in Children Under 2 Years of Age". Our primary outcome is to assess the safety of Dotarem in children \<2 years old up to 24 hours after Dotarem injection. Patients will be monitored for any adverse events that occur for 2 hours following the completion of the MRI exam. The type of event, time of onset, duration of symptoms, intensit...
What is the current status of trial NCT02609919?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2016-01. Estimated completion is 2019-07-19.
What conditions does trial NCT02609919 study?
This clinical trial studies the following conditions: Adverse Reaction to Drug, Allergic Reaction to Contrast Media.
What interventions are being tested in trial NCT02609919?
The interventions under investigation include: Gadoteric Acid (DRUG).
Who is sponsoring clinical trial NCT02609919?
This trial is sponsored by St. Louis University, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02609919 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia